INSERM U1051 — ERA-LEARN

Skip to content
Skip to footer

Service Navigation

Home
About
Contact
newsletter
Twitter

Main Menu Search

Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Home
Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Modulation of Neuregulin signaling as an effective strategy to treat hereditary neuropathies (Charcot-Marie-Tooth disease)

Home
Explore Partnerships
Partnerships
E-Rare-3
E-Rare-3 JTC 2015
Modulation of Neuregulin signaling as an effective strategy to treat hereditary neuropathies (Charcot-Marie-Tooth disease)
INSERM U1051

Full name	INSERM U1051
Short name
Type of organisation	Academia, Public
Partner Role	Partner
Country	France

Back to project overview

ERA-LEARN has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 811171.

Sitemap
Imprint
Privacy Policy
Submit accessibility issues
Accessibility Statement

Follow us on Twitter
@ERALEARN_EU

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.